Sharkey Howes & Javer Purchases New Shares in HCA Healthcare, Inc. (NYSE:HCA)

Sharkey Howes & Javer purchased a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 1,010 shares of the company’s stock, valued at approximately $410,000.

Other large investors also recently added to or reduced their stakes in the company. MFA Wealth Advisors LLC purchased a new position in HCA Healthcare during the 2nd quarter valued at about $27,000. Unique Wealth Strategies LLC purchased a new position in shares of HCA Healthcare during the 2nd quarter valued at $28,000. Bangor Savings Bank raised its holdings in shares of HCA Healthcare by 112.5% during the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after acquiring an additional 45 shares in the last quarter. GPS Wealth Strategies Group LLC increased its position in HCA Healthcare by 284.0% in the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after purchasing an additional 71 shares during the last quarter. Finally, Benjamin F. Edwards & Company Inc. bought a new stake in shares of HCA Healthcare in the 2nd quarter valued at approximately $33,000. 62.73% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now owns 29,678 shares in the company, valued at approximately $11,438,494.76. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In related news, SVP Kathleen M. Whalen sold 2,987 shares of the business’s stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total value of $1,085,804.37. Following the completion of the transaction, the senior vice president now directly owns 9,454 shares in the company, valued at approximately $3,436,623.54. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares of the company’s stock, valued at $11,438,494.76. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 17,202 shares of company stock valued at $6,407,273. Company insiders own 1.60% of the company’s stock.

Analysts Set New Price Targets

HCA has been the subject of several recent research reports. Morgan Stanley assumed coverage on shares of HCA Healthcare in a research report on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 target price for the company. Barclays boosted their price target on HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 24th. Oppenheimer boosted their target price on HCA Healthcare from $345.00 to $390.00 and gave the stock an “outperform” rating in a report on Wednesday, July 24th. Wolfe Research raised shares of HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. Finally, KeyCorp began coverage on HCA Healthcare in a research report on Friday, October 11th. They issued an “overweight” rating and a $475.00 price target on the stock. Five research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and four have assigned a strong buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $365.65.

HCA Healthcare Price Performance

Shares of NYSE HCA traded down $1.70 during mid-day trading on Monday, hitting $413.84. 365,151 shares of the stock were exchanged, compared to its average volume of 1,136,178. The company has a market cap of $108.39 billion, a P/E ratio of 20.71, a PEG ratio of 1.44 and a beta of 1.67. The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.06. HCA Healthcare, Inc. has a twelve month low of $215.96 and a twelve month high of $417.14. The stock’s fifty day simple moving average is $392.18 and its two-hundred day simple moving average is $350.50.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, topping the consensus estimate of $4.97 by $0.53. The company had revenue of $17.49 billion for the quarter, compared to analysts’ expectations of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The business’s revenue for the quarter was up 10.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $4.29 earnings per share. As a group, analysts forecast that HCA Healthcare, Inc. will post 22.51 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, September 30th. Investors of record on Monday, September 16th were issued a $0.66 dividend. The ex-dividend date was Monday, September 16th. This represents a $2.64 annualized dividend and a yield of 0.64%. HCA Healthcare’s dividend payout ratio is currently 13.16%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.